Regulation of mitochondrial nutrient and energy metabolism by BCL-2 family proteins

Trends in Endocrinology and Metabolism

Volumn 26, Issue 4, 2015, Pages 165-175

  Giménez Cassina, Alfredo ^a,b   Danial, Nika N ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

BCL 2 proteins; Fatty acids; Glucose; Metabolism; Mitochondria; OXPHOS

Indexed keywords

CARBON; PROTEIN BCL 2;

APOPTOSIS; CARBON UTILIZATION; CELL ORGANELLE; CELL SURVIVAL; ELECTRON TRANSPORT; ENERGY METABOLISM; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; NUTRIENT; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; ADVERSE EFFECTS; ANIMAL; BIOLOGICAL MODEL; CALORIC INTAKE; DIET; ENZYMOLOGY; HOMEOSTASIS; METABOLISM; MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; PROTEIN TRANSPORT;

ANIMALS; DIET; ENERGY INTAKE; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; OXIDATIVE PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84933677674     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2015.02.004     Document Type: Review

References (102)

1. Chi X., et al. Regulating cell death at, on, and in membranes. Biochim. Biophys. Acta 2014, 1843:2100-2113.
2. Czabotar P.E., et al. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat. Rev. Mol. Cell Biol. 2014, 15:49-63.
3. Moldoveanu T., et al. Many players in BCL-2 family affairs. Trends Biochem. Sci. 2014, 39:101-111.
4. Danial N.N., Korsmeyer S.J. Cell death: critical control points. Cell 2004, 116:205-219.
5. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9:47-59.
6. Wei M.C., et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001, 292:727-730.
7. Zhang T., Saghatelian A. Emerging roles of lipids in BCL-2 family-regulated apoptosis. Biochim. Biophys. Acta 2013, 1831:1542-1554.
8. Llambi F., et al. A unified model of mammalian BCL-2 protein family interactions at the mitochondria. Mol. Cell 2011, 44:517-531.
9. Dlugosz P.J., et al. Bcl-2 changes conformation to inhibit Bax oligomerization. EMBO J. 2006, 25:2287-2296.
10. Gavathiotis E., et al. BAX activation is initiated at a novel interaction site. Nature 2008, 455:1076-1081.
11. Tan C., et al. Auto-activation of the apoptosis protein Bax increases mitochondrial membrane permeability and is inhibited by Bcl-2. J. Biol. Chem. 2006, 281:14764-14775.
12. Montessuit S., et al. Membrane remodeling induced by the dynamin-related protein Drp1 stimulates Bax oligomerization. Cell 2010, 142:889-901.
13. Ott M., et al. Mitochondrial targeting of tBid/Bax: a role for the TOM complex?. Cell Death Differ. 2009, 16:1075-1082.
14. Zaltsman Y., et al. MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria. Nat. Cell Biol. 2010, 12:553-562.
15. Kale J., et al. Shedding light on apoptosis at subcellular membranes. Cell 2012, 151:1179-1184.
16. Walensky L.D., Gavathiotis E. BAX unleashed: the biochemical transformation of an inactive cytosolic monomer into a toxic mitochondrial pore. Trends Biochem. Sci. 2011, 36:642-652.
17. Bonneau B., et al. Non-apoptotic roles of Bcl-2 family: the calcium connection. Biochim. Biophys. Acta 2013, 1833:1755-1765.
18. Danial N.N., et al. Homeostatic functions of BCL-2 proteins beyond apoptosis. Adv. Exp. Med. Biol. 2010, 687:1-32.
19. Hardwick J.M., et al. Multipolar functions of BCL-2 proteins link energetics to apoptosis. Trends Cell Biol. 2012, 22:318-328.
20. Green D.R., et al. Metabolic control of cell death. Science 2014, 345:1250256.
21. Stanley I.A., et al. Changing appetites: the adaptive advantages of fuel choice. Trends Cell Biol. 2014, 24:118-127.
22. Kaelin W.G., McKnight S.L. Influence of metabolism on epigenetics and disease. Cell 2013, 153:56-69.
23. Lu C., Thompson C.B. Metabolic regulation of epigenetics. Cell Metab. 2012, 16:9-17.
24. Danial N.N., et al. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 2003, 424:952-956.
25. Danial N.N., et al. Dual role of proapoptotic BAD in insulin secretion and beta cell survival. Nat. Med. 2008, 14:144-153.
26. Gimenez-Cassina A., et al. Regulation of hepatic energy metabolism and gluconeogenesis by BAD. Cell Metab. 2014, 19:272-284.
27. Szlyk B., et al. A phospho-BAD BH3 helix activates glucokinase by a mechanism distinct from that of allosteric activators. Nat. Struct. Mol. Biol. 2014, 21:36-42.
28. Matschinsky F.M. Assessing the potential of glucokinase activators in diabetes therapy. Nat. Rev. Drug Discov. 2009, 8:399-416.
29. Danial N.N. BAD: undertaker by night, candyman by day. Oncogene 2008, 27(Suppl. 1):S53-S70.
30. Liu S., et al. Insulin signaling regulates mitochondrial function in pancreatic beta-cells. PLoS ONE 2009, 4:e7983.
31. Prentki M., et al. Metabolic signaling in fuel-induced insulin secretion. Cell Metab. 2013, 18:162-185.
32. Ljubicic S., et al. Phospho-BAD BH3 mimicry protects beta cells and restores functional beta cell mass in diabetes. Cell Rep. 2015, 10:497-504.
33. Porat S., et al. Control of pancreatic beta cell regeneration by glucose metabolism. Cell Metab. 2011, 13:440-449.
34. Salpeter S.J., et al. Glucose and aging control the quiescence period that follows pancreatic beta cell replication. Development 2010, 137:3205-3213.
35. Wang Z., et al. Pancreatic beta cell dedifferentiation in diabetes and redifferentiation following insulin therapy. Cell Metab. 2014, 19:872-882.
36. Wei P., et al. Effects of glucokinase activators GKA50 and LY2121260 on proliferation and apoptosis in pancreatic INS-1 beta cells. Diabetologia 2009, 52:2142-2150.
37. Lin H.V., Accili D. Hormonal regulation of hepatic glucose production in health and disease. Cell Metab. 2011, 14:9-19.
38. Satapati S., et al. Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver. J. Lipid Res. 2012, 53:1080-1092.
39. Glick D., et al. BNip3 regulates mitochondrial function and lipid metabolism in the liver. Mol. Cell. Biol. 2012, 32:2570-2584.
40. Landes T., et al. The BH3-only Bnip3 binds to the dynamin Opa1 to promote mitochondrial fragmentation and apoptosis by distinct mechanisms. EMBO Rep. 2010, 11:459-465.
41. Rikka S., et al. Bnip3 impairs mitochondrial bioenergetics and stimulates mitochondrial turnover. Cell Death Differ. 2011, 18:721-731.
42. Liesa M., Shirihai O.S. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 2013, 17:491-506.
43. Friedman J.R., Nunnari J. Mitochondrial form and function. Nature 2014, 505:335-343.
44. Deng H., et al. Phosphorylation of Bad at Thr-201 by JNK1 promotes glycolysis through activation of phosphofructokinase-1. J. Biol. Chem. 2008, 283:20754-20760.
45. Gimenez-Cassina A., et al. BAD-dependent regulation of fuel metabolism and K(ATP) channel activity confers resistance to epileptic seizures. Neuron 2012, 74:719-730.
46. Zielke H.R., et al. Direct measurement of oxidative metabolism in the living brain by microdialysis: a review. J. Neurochem. 2009, 109(Suppl. 1):24-29.
47. Mergenthaler P., et al. Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci. 2013, 36:587-597.
48. DeVivo D.C., et al. Chronic ketosis and cerebral metabolism. Ann. Neurol. 1978, 3:331-337.
49. Owen O.E., et al. Brain metabolism during fasting. J. Clin. Invest. 1967, 46:1589-1595.
50. Auestad N., et al. Fatty acid oxidation and ketogenesis by astrocytes in primary culture. J. Neurochem. 1991, 56:1376-1386.
51. Blazquez C., et al. Role of carnitine palmitoyltransferase I in the control of ketogenesis in primary cultures of rat astrocytes. J. Neurochem. 1998, 71:1597-1606.
52. Hartman A.L., et al. The neuropharmacology of the ketogenic diet. Pediatr. Neurol. 2007, 36:281-292.
53. Lutas A., Yellen G. The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci. 2013, 36:32-40.
54. Dunn-Meynell A.A., et al. Distribution and phenotype of neurons containing the ATP-sensitive K+ channel in rat brain. Brain Res. 1998, 814:41-54.
55. Karschin C., et al. Overlapping distribution of K(ATP) channel-forming Kir6.2 subunit and the sulfonylurea receptor SUR1 in rodent brain. FEBS Lett. 1997, 401:59-64.
56. Zawar C., et al. Cell-type specific expression of ATP-sensitive potassium channels in the rat hippocampus. J. Physiol. 1999, 514:327-341.
57. Ma W., et al. Ketogenic diet metabolites reduce firing in central neurons by opening K(ATP) channels. J. Neurosci. 2007, 27:3618-3625.
58. Tanner G.R., et al. Single K ATP channel opening in response to action potential firing in mouse dentate granule neurons. J. Neurosci. 2011, 31:8689-8696.
59. Lowman X.H., et al. The proapoptotic function of Noxa in human leukemia cells is regulated by the kinase Cdk5 and by glucose. Mol. Cell 2010, 40:823-833.
60. MacIver N.J., et al. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 2013, 31:259-283.
61. Pearce E.L., et al. Fueling immunity: insights into metabolism and lymphocyte function. Science 2013, 342:1242454.
62. Alves N.L., et al. The Noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells. Immunity 2006, 24:703-716.
63. Ghesquiere B., et al. Metabolism of stromal and immune cells in health and disease. Nature 2014, 511:167-176.
64. Ploner C., et al. Noxa: at the tip of the balance between life and death. Oncogene 2008, 27(Suppl. 1):S84-S92.
65. Wensveen F.M., et al. Pro-apoptotic protein Noxa regulates memory T cell population size and protects against lethal immunopathology. J. Immunol. 2013, 190:1180-1191.
66. Wensveen F.M., et al. Apoptosis threshold set by Noxa and Mcl-1 after T cell activation regulates competitive selection of high-affinity clones. Immunity 2010, 32:754-765.
67. Finkel T. Signal transduction by reactive oxygen species. J. Cell Biol. 2011, 194:7-15.
68. Murphy M.P., et al. Unraveling the biological roles of reactive oxygen species. Cell Metab. 2011, 13:361-366.
69. Sena L.A., Chandel N.S. Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 2012, 48:158-167.
70. Baker M.J., et al. Quality control of mitochondrial proteostasis. Cold Spring Harb. Perspect. Biol. 2011, 3.
71. Nunnari J., Suomalainen A. Mitochondria: in sickness and in health. Cell 2012, 148:1145-1159.
72. Tatsuta T., et al. Mitochondrial lipid trafficking. Trends Cell Biol. 2014, 24:44-52.
73. Acin-Perez R., Enriquez J.A. The function of the respiratory supercomplexes: the plasticity model. Biochim. Biophys. Acta 2014, 1837:444-450.
74. Lenaz G., Genova M.L. Supramolecular organisation of the mitochondrial respiratory chain: a new challenge for the mechanism and control of oxidative phosphorylation. Adv. Exp. Med. Biol. 2012, 748:107-144.
75. Perciavalle R.M., et al. Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration. Nat. Cell Biol. 2012, 14:575-583.
76. Wang X., et al. Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction. Genes Dev. 2013, 27:1351-1364.
77. Huang C.R., Yang-Yen H.F. The fast-mobility isoform of mouse Mcl-1 is a mitochondrial matrix-localized protein with attenuated anti-apoptotic activity. FEBS Lett. 2010, 584:3323-3330.
78. Warr M.R., et al. Mitochondrion-dependent N-terminal processing of outer membrane Mcl-1 protein removes an essential Mule/Lasu1 protein-binding site. J. Biol. Chem. 2011, 286:25098-25107.
79. Lapuente-Brun E., et al. Supercomplex assembly determines electron flux in the mitochondrial electron transport chain. Science 2013, 340:1567-1570.
80. Cogliati S., et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell 2013, 155:160-171.
81. Chen Z.X., Pervaiz S. Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells. Cell Death Differ. 2007, 14:1617-1627.
82. Chen Z.X., Pervaiz S. Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2. Cell Death Differ. 2010, 17:408-420.
83. Alavian K.N., et al. Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase. Nat. Cell Biol. 2011, 13:1224-1233.
84. Chen Y.B., et al. Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential. J. Cell Biol. 2011, 195:263-276.
85. Yi C.H., et al. Metabolic regulation of protein N-alpha-acetylation by Bcl-xL promotes cell survival. Cell 2011, 146:607-620.
86. Maryanovich M., et al. The ATM-BID pathway regulates quiescence and survival of haematopoietic stem cells. Nat. Cell Biol. 2012, 14:535-541.
87. Bernardi P. The mitochondrial permeability transition pore: a mystery solved?. Front. Physiol. 2013, 4:95.
88. Colombini M. VDAC structure, selectivity, and dynamics. Biochim. Biophys. Acta 2012, 1818:1457-1465.
89. Rostovtseva T.K. VDAC structure, function, and regulation of mitochondrial and cellular metabolism. Biochim. Biophys. Acta 2012, 1818:1437.
90. Shoshan-Barmatz V., et al. VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol. Aspects Med. 2010, 31:227-285.
91. McCommis K.S., Baines C.P. The role of VDAC in cell death: friend or foe?. Biochim. Biophys. Acta 2012, 1818:1444-1450.
92. Rostovtseva T.K., et al. On the role of VDAC in apoptosis: fact and fiction. J. Bioenerg. Biomembr. 2005, 37:129-142.
93. Hiller S., et al. Solution structure of the integral human membrane protein VDAC-1 in detergent micelles. Science 2008, 321:1206-1210.
94. Malia T.J., Wagner G. NMR structural investigation of the mitochondrial outer membrane protein VDAC and its interaction with antiapoptotic Bcl-xL. Biochemistry 2007, 46:514-525.
95. Vander Heiden M.G., et al. Bcl-xL promotes the open configuration of the voltage-dependent anion channel and metabolite passage through the outer mitochondrial membrane. J. Biol. Chem. 2001, 276:19414-19419.
96. Lee A.C., et al. Beta-NADH decreases the permeability of the mitochondrial outer membrane to ADP by a factor of 6. J. Biol. Chem. 1994, 269:30974-30980.
97. Bonnefont J.P., et al. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol. Aspects Med. 2004, 25:495-520.
98. Giordano A., et al. tBid induces alterations of mitochondrial fatty acid oxidation flux by malonyl-CoA-independent inhibition of carnitine palmitoyltransferase-1. Cell Death Differ. 2005, 12:603-613.
99. Schug Z.T., Gottlieb E. Cardiolipin acts as a mitochondrial signalling platform to launch apoptosis. Biochim. Biophys. Acta 2009, 1788:2022-2031.
100. Raemy E., Martinou J.C. Involvement of cardiolipin in tBID-induced activation of BAX during apoptosis. Chem. Phys. Lipids 2014, 179:70-74.
101. Paumen M.B., et al. Direct interaction of the mitochondrial membrane protein carnitine palmitoyltransferase I with Bcl-2. Biochem. Biophys. Res. Commun. 1997, 231:523-525.
102. Paumen M.B., et al. Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. J. Biol. Chem. 1997, 272:3324-3329.